EINDHOVEN, Netherlands & LAUSANNE, Switzerland–(BUSINESS WIRE)–ONWARD Medical N.V. (Euronext: ONWD), the medical know-how firm creating progressive therapies to revive motion, independence, and well being in individuals with spinal cord injury (SCI), at the moment introduced that administration will take part within the following upcoming investor occasions in September:
-
KBC Securities Digital Life Sciences Convention
September 16, 2022
Dave Marver, CEO, and Lara Smith Weber, CFO, will take part within the convention and provides an organization presentation.
-
btov Portfolio Day
September 21, 2022
Berlin, Germany
Lara Smith Weber, CFO, will give an organization presentation.
Info on upcoming conferences is offered within the investor part of the ONWARD web site at https://ir.onwd.com/news-events.
About ONWARD Medical
ONWARD is a medical know-how firm creating progressive therapies to revive motion, independence, and well being in individuals with spinal cord accidents. ONWARD’s work builds on greater than a decade of primary science and preclinical analysis performed on the world’s main neuroscience laboratories. ONWARD’s ARC Remedy, which may be delivered by implantable (ARCIM) or exterior (ARCEX) programs, is designed to ship focused, programmed spinal cord stimulation to revive motion and different capabilities in individuals with spinal cord injury, in the end bettering their high quality of life. ONWARD has acquired three Breakthrough Machine Designations from the U.S. FDA, encompassing each ARCIM and ARCEX. ARCEX is an exterior, non-invasive platform consisting of a wearable stimulator and wi-fi programmer. The corporate’s first pivotal trial, known as Up-LIFT, evaluating the power of ARCEX Remedy to enhance higher extremity energy and performance, accomplished enrollment in December 2021 with 65 topics worldwide. Topline outcomes are anticipated in September 2022. ARCIM consists of an implantable pulse generator and lead positioned close to the spinal cord. The corporate accomplished its first-in-human use of the ARCIM neurostimulator in Might 2022.
ONWARD is headquartered on the Excessive Tech Campus in Eindhoven, the Netherlands. It maintains a big crew in Lausanne, Switzerland, and has a rising U.S. presence in Boston, Massachusetts, USA. For added details about the corporate, please go to ONWD.com. To entry our 2022 Monetary Calendar, please go to IR.ONWD.com.
Disclaimer
Sure statements, beliefs, and opinions on this press launch are forward-looking, which replicate the Firm or, as applicable, the Firm administrators’ present expectations and projections about future occasions. By their nature, forward-looking statements contain a lot of dangers, uncertainties and assumptions that would trigger precise outcomes or occasions to vary materially from these expressed or implied by the forward-looking statements. These dangers, uncertainties and assumptions might adversely have an effect on the result and monetary results of the plans and occasions described herein. A large number of things together with, however not restricted to, adjustments in demand, competitors and know-how, could cause precise occasions, efficiency or outcomes to vary considerably from any anticipated growth. Ahead trying statements contained on this press launch concerning previous traits or actions shouldn’t be taken as a illustration that such traits or actions will proceed sooner or later. In consequence, the Firm expressly disclaims any obligation or enterprise to launch any replace or revisions to any forward-looking statements on this press launch on account of any change in expectations or any change in occasions, circumstances, assumptions or circumstances on which these forward-looking statements are based mostly. Neither the Firm nor its advisers or representatives nor any of its subsidiary undertakings or any such particular person’s officers or staff ensures that the assumptions underlying such forward-looking statements are free from errors nor does both settle for any duty for the longer term accuracy of the forward-looking statements contained on this press launch or the precise prevalence of the forecasted developments. You shouldn’t place undue reliance on forward-looking statements, which converse solely as of the date of this press launch.
Discussion about this post